Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_1
2
67%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)

Detailed Status

Recruiting1
Terminated1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
50.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (66.7%)
N/A1 (33.3%)

Trials by Status

recruiting133%
terminated133%
completed133%

Recent Activity

1 active trials
Showing 3 of 3
recruitingphase_1

A Study of Food Effect on Tersolisib (LY4064809) in Healthy Participants

NCT07662798
terminatedphase_1

Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose.

NCT05276492
completednot_applicable

Effect of Meal Composition on the Responses to Meal Ingestion

NCT03084276

Clinical Trials (3)

Showing 3 of 3 trials
NCT07662798Phase 1

A Study of Food Effect on Tersolisib (LY4064809) in Healthy Participants

Recruiting
NCT05276492Phase 1

Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose.

Terminated
NCT03084276Not Applicable

Effect of Meal Composition on the Responses to Meal Ingestion

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3